Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-22T16:25:44.919Z Has data issue: false hasContentIssue false
  • English
  • Français

Hepatitis B markers in Lancashire police officers

Published online by Cambridge University Press:  19 October 2009

P. Morgan-Capner ,
P. Hudson  and
A. Armstrong
P. Morgan-Capner
Affiliation:
Department of Virology, Pathology Laboratory, Preston Infirmary, Preston PR1 6PS
P. Hudson
Affiliation:
Department of Virology, Pathology Laboratory, Preston Infirmary, Preston PR1 6PS
A. Armstrong
Affiliation:
Police Federation, Federation Office, Police Headquarters, Hutton, Preston PR4 5SB
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A total of 284 Lancashire police officers each with a minimum of 5 years experience was tested for evidence of hepatitis B infection. None was hepatitis B surface antigen positive (HBsAg). Three were positive for both antibody to hepatitis B core antigen (anti-HBc) and HBsAg (anti-HBs). Five were positive for anti-HBc alone. Thus the overall prevalence was 2·8% which is within the range reported for blood donors in the UK. There was no association with working in the drug squad or custody office but there was a higher prevalence in those who had worked in the scene-of-crime's squad. However, the numbers were small, and of this group of 28 officers, 2 of the 3 with detectable hepatitis B markers were positive for anti-HBc alone. Therefore for police officers in mixed rural/urban areas of the UK, routine administration of hepatitis B vaccine is not justified although special consideration should be given to those working in selected groups. Further studies are required to ascertain whether there may be an increased risk for police officers working in conurbations.

Type
Research Article
Information
Epidemiology & Infection , Volume 100 , Issue 1 , February 1988 , pp. 145 - 151
Copyright
Copyright © Cambridge University Press 1988

References

REFERENCES

Abbas, A. M. A., Denton, M. D. & Francis, R. A. (1985). Prevalence of hepatitis B markers among district general hospital staff. British Medical Journal 290, 1212.Google Scholar
Anderson, C. C., Contreras, M., Barbara, J. A. J. & Mijovic, V. (1987). Surrogate testing for non-A, non-B hepatitis. Lancet i, 912.Google Scholar
Archer, A. C., Cohen, B. J. & Mortimer, P. P. (1983). The value of screening blood donors for antibody to hepatitis B core antigen. Journal of Clinical Pathology 36, 924–928.CrossRefGoogle ScholarPubMed
Cumming, C. G., Peutherer, J. F. & Smith, G. L. F. (1986). The prevalence of hepatitis B serological markers in dental personnel. Journal of Infection 12, 157–159.Google Scholar
Drinhardt, F. & Zuckerman, A. J. (1985). Immunization against hepatitis B: report on a WHO meeting on viral hepatitis in Europe. Journal of Medical Virology 17, 209–217.Google Scholar
Fagan, E. (1986). Response to question. British Medical Journal 293, 687.Google Scholar
Fagan, E. A., Tolley, P., Smith, H. M., Peters, M. P., Doleman, J., Elliott, P., Williams, R. & Eddleston, A. L. W. F. (1987). Hepatitis B vaccine: immunogenicity and follow-up including two year booster doses in high-risk health care personnel in a London teaching hospital. Journal of Medical Virology 21, 49–56.Google Scholar
Follett, E. A. C., Barr, A., Crawford, R. J. & Mitchell, R. (1980). Viral hepatitis markers in blood donors and patients with a history of jaundice. Lancet i, 246–249.Google Scholar
Gillon, J., Hussey, A. J., Howe, S. P., Beckett, G. J. & Prescott, R. J. (1987). Non-A, non-B hepatitis surrogate testing of blood donations. Lancet i, 1366–1367.Google Scholar
Holt, P. A., Goodall, B., Lees, E. M. & Hambling, M. H. (1986). Prevalence of hepatitis B markers in patients and staff in a hospital for the mentally handicapped. Journal of Hospital Infection 7, 26–33.Google Scholar
Peterkin, M. & Crawford, R. J. (1986). Hepatitis B vaccine for police forces? Lancet ii, 1458.Google Scholar
Peterkin, M. A., Crawford, R. J., Mitchell, R. & Mclay, W. D. (1986). Hepatitis B and the police. Communicable Disease Surveillance Weekly Report. No 32, 7–9.Google Scholar
Polakoff, S. (1986). Acute viral hepatitis B: laboratory reports 1980–4. British Medical Journal 293, 37–38.Google Scholar
Seeff, L. B., Beebe, G. W., Hoofnagle, J. H., Norman, J. E., Buskell-Bales, Z., Waggoner, J. G., Kaplowitz, N., Koff, R. S., Petrini, J. L., Schiff, E. R., Shorey, J. & Stanley, M. M. (1987). A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. New England Journal of Medicine 316, 965–970.CrossRefGoogle ScholarPubMed
Smith, C. E. T. (1987). A study of the prevalence of markers of hepatitis B infection in hospital staff. Journal of Hospital Infection 9, 39–42.CrossRefGoogle ScholarPubMed
Smith, T. (1986). Protecting policeman against hepatitis B. Occupational Health 38, 229–230.Google Scholar
Tedder, R. S. (1983). Hepatitis B vaccination policy. Lancet i, 533.Google Scholar
Tedder, R. S., Cameron, C. H., Wilson-Croome, R., Howell, D. R., Colgrove, A. & Barbara, J. A. J. (1980). Contrasting patterns and frequency of antibodies to the surface, core and e antigens of hepatitis B virus in blood donors and in homosexual patients. Journal of Medical Virology 6, 323–332.Google Scholar
Vandervelde, E. M. & Mortimer, P. P. (1985). New hepatitis B vaccines. British Medical Journal 290, 787.Google Scholar
Zuckerman, A. J. (1984). Who should be immunized against hepatitis B? British Medical Journal 289, 1243–1244.Google Scholar
Zuckerman, A. J. (1986). Novel hepatitis B vaccines. Journal of Infection 13, (Supp A), 61–71.Google Scholar